Live Deals

Active Portfolio

Enabling precision genetic medicine

2019 Seed+
2017 Seed
  • Universal delivery platform for gene therapies
  • Rapid, affordable, targeted to specific cell types
  • Disrupting $100B+ Hematology Market
Explore Offered By: Bioverge Funds Management LLC

Changing the way cancer is treated

Seed
Series A
Pre-B
Series B
  • Platform identifies personalized drug combinations
  • Highly accurate drug response predictions
  • Multiple academic/pharma partnerships underway
Explore Offered By: Bioverge Funds Management LLC

Helping global populations live chronic disease-free

2018 Seed
  • Digital diabetes prevention 2X effective as drugs
  • Reducing risk of Type-2 Diabetes by 60%
  • International partnership with Merck KGaA
Explore Offered By: Bioverge Funds Management LLC

Crowdsourcing medical expertise

2016 Seed
  • Solving elusive cases (avg: 6+ years, 8+ doctors)
  • 1M+ unique monthly visitors
  • 5-18X ROI for doctors/health plans/employers
Explore Offered By: Bioverge Funds Management LLC

Revolutionizing the way the world views science

2017 Series A
2016 Seed
  • World’s first hybrid microscope
  • Easy-to-use, stunning digital display
  • 8X increase in researcher productivity
Explore Offered By: Bioverge Funds Management LLC

Early Diagnosis and Treatment of Alzheimer's Without Drugs

2019 Seed
  • 250M Alzheimer's Patients thru 2050 = $5.4T Market
  • AD Drugs Failing in Humans; Only Treating Symptoms
  • Predict AD Risk, Prevent & Treat Underlying Cause
Explore Offered By: Bioverge Funds Management LLC

Disruptive Approach to ALS with Potential to be First Viable Treatment for Patients

2019 Seed
  • Potential to Slow/halt Progression of ALS
  • Funding and Strategic Support from Amgen Ventures
  • World-class Team (Medtronic, J&J, Harvard, MIT)
Explore Offered By: Bioverge Funds Management LLC

AI-Powered Drug Discovery for Neurodegenerative Diseases

2018 Seed
  • Leading edge biology combined w/ machine learning
  • Female Founder & CEO leads top-tier team
  • World-class research partnerships
Explore Offered By: Bioverge Funds Management LLC

BV Showcase

Mining the microbiome for novel therapeutic molecules

  • Computational drug discovery from within the body
  • Vast Data Engine: 10k patient samples, 38TB data
  • 2 Paid industry clients, 7 partner clinical orgs
Explore Offered By: Bioverge Inc

Next-generation 3D bioprinting platform

  • Proprietary, light-based 3D bioprinting
  • 10x Speed and 5x Resolution
  • Most advanced engineered tissue ever
Explore Offered By: Bioverge Inc

Revolutionizing preclinical drug discovery research

  • 50% cost reductions, 70% efficiency improvements
  • Tier 1 paid clients: Novartis, Denali, Jackson Lab
  • Vetted, Awarded $1.85M in funding from NIH
Explore Offered By: Bioverge Inc
The Bioverge platform is host to both Regulation Crowdfunding and Regulation D offering types. Reg CF offerings are provided by Bioverge Portal LLC and Reg D offering are provided by Bioverge Funds Management LLC. Companies designated as BV Showcase are enrolled in a program managed by Bioverge Inc and are not associated with an offering on the Bioverge platform.